Search results
Results from the WOW.Com Content Network
Fluorouracil (5-FU, 5-fluorouracil), sold under the brand name Adrucil among others, is a cytotoxic chemotherapy medication used to treat cancer. [3] By intravenous injection it is used for treatment of colorectal cancer , oesophageal cancer , stomach cancer , pancreatic cancer , breast cancer , and cervical cancer . [ 3 ]
Short-term use increases the risk of minor and major adverse effects. [7] Common side effects include dizziness, feeling tired, vomiting, and hallucinations. [7] Long-term effects of cannabis are not clear. [7] Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by ...
In December 2018, during a Q&A session with constituents on Twitter, Governor Wolf tweeted: "I think it is time for Pennsylvania to take a serious and honest look at legalizing recreational marijuana." [17] One month later, Wolf announced a statewide tour by Lieutenant Governor John Fetterman to gather public input on the idea. [18]
The information state police provide the public through its website, psp.pa.gov, reports “According to the U.S. DOJ (Department of Justice), possession of a valid Medical Marijuana Card and/or ...
The exact medications recommended will vary by country and the individual treatment center, but the following gives an example of the WHO approach to treating chronic pain with medications. If, at any point, treatment fails to provide adequate pain relief, then the doctor and patient move onto the next step.
Many people try marijuana, and some develop an addiction leading to their lives — and the lives of others — being turned upside down, Dr. Mark Hurst writes. 'Marijuana is, in fact, a problem.'
[26] [27] [28] The most common adverse effects in Phase III trials were dizziness (25%), drowsiness (8%) and disorientation (4%); 12% of subjects stopped taking the drug because of the side effects. No investigations regarding the potential for dependence are available, but such a potential is unlikely considering the pharmacological properties ...
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]